Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Yi Xue Za Zhi ; 100(17): 1332-1335, 2020 May 05.
Article in Chinese | MEDLINE | ID: mdl-32375442

ABSTRACT

Objective: To compare the clinical application effect of totally implantable venous access ports (TIVAP) via the internal jugular vein,the subclavian vein and the brachiocephalic veins under the guidance of ultrasound combined with DSA. Methods: The clinical materials of 346 patients (162 males and 184 females) who implanted TIVAP in intervention Department of Jiangsu Cancer Hospital between August 2018 and January 2019 were retrospectively reviewed and the average age was (57±12) years (17 to 83 years). The patients were divided into three groups according to the different implantation approaches. One hundred and twenty-six patients (67 males and 59 females) were group A who implanted from the internal jugular vein and the average age was (52±11) years,114 patients (52 males and 62 females) were group B who implanted from the subclavian vein and the average age was (58±10) years,106 patients (43 males and 63 females) were group C who implanted from the brachiocephalic vein and the average age was (60±9) years.The first-puncture success rate,operating time,implanting length,intraoperative pain score, one month comfort rating after surgery, unscheduled decannulation rates, early and late complication rates were compared among three groups. Results: All the patients implanted the TIVAP successfully.There were no significant differences about the first-puncture success rate (χ(2)=1.375,P=0.503),operating time (F=0.968, P=0.624), unscheduled decannulation rates (χ(2)=1.570, P=0.456), and the total pipe length among the three groups (F=0.821, P=0.441),while the catheter length inside the blood vessel were the shortest in group C (F= 263.618, P=0.000), and the one month comfort rating after surgery of group C were higher compared with group A and B (F=52.248,P=0.000).Pitch-off syndrome was a unique complication of group B (χ(2)=6.159,P=0.046) and other complications were no significant differences (P>0.05). Conclusion: There are high accuracy and safety among three implantation approaches,and the approach via brachiocephalic vein under the guidance of ultrasound combined with DSA is more comfortable and lower complication rates, which could be priority to choose.


Subject(s)
Catheterization, Central Venous , Central Venous Catheters , Adult , Aged , Catheters, Indwelling , Female , Humans , Jugular Veins , Male , Middle Aged , Retrospective Studies
2.
Clin Exp Dermatol ; 44(6): 620-624, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30793382

ABSTRACT

BACKGROUND: Despite its high contagiousness, high recurrence rate and potential for malignant transformation, effective treatments for condyloma acuminatum (CA) have not yet been developed. Accordingly, it is necessary to clarify the mechanisms underlying CA development. AIM: To investigate the expression and significance of the proteins Wnt-1 and TSLC1 in patients with CA and in normal foreskin controls. METHODS: Wnt-1 and TSLC1 were assessed by immunohistochemistry in 45 patients with CA. RESULTS: Positive expression rates of Wnt-1 and TSLC1 were 82.22% (37/45) and 37.78% (17/45), respectively, in CA tissues, and 29.17% (7/24) and 91.67% (22/24), respectively, in normal foreskin controls. Wnt-1 expression intensity in CA was markedly higher (positive to strongly positive) than that in normal controls (negative to weakly positive), whereas TSLC1 expression intensity ranged from weakly positive to positive in CA, and nearly strongly positive in the normal control group. The differences in the positive expression rate and expression intensity of Wnt-1 and TSLC1 between the two groups were statistically significant (P < 0.05). In addition, Wnt-1 and TSLC1 were negatively correlated. (r = -0.336, P < 0.05). CONCLUSIONS: Overexpression of Wnt-1 and low expression of TSLC1 may be associated with the growth of CA. These findings may provide a basis for the development of therapies to prevent recurrence or malignant transformation of CA.


Subject(s)
Cell Adhesion Molecule-1/metabolism , Condylomata Acuminata/metabolism , Wnt1 Protein/metabolism , Adolescent , Adult , Condylomata Acuminata/pathology , Female , Genes, Tumor Suppressor , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Recurrence, Local , Papillomavirus Infections/metabolism , Proto-Oncogenes , Tumor Suppressor Proteins , Young Adult
3.
J Biol Regul Homeost Agents ; 30(3): 773-776, 2016.
Article in English | MEDLINE | ID: mdl-27655496

ABSTRACT

The objective of this study was to explore the expressions and significance of NDRG1 (N-myc downregulated gene family 1), VEGF (vascular endothelial growth factor) and Ki-67 in lesions of Condyloma Acuminatum (CA). Immunohistochemistry was adopted to measure the expressions of NDRG1, VEGF and Ki-67 in 48 cases of CA and 18 normal skin controls. The positive rates of NDRG1, VEGF and Ki-67 were 63. 83.33% (40/48), 93.75% (45/48) and 85.42% (41/48) in the CA tissues, and 27.78% (5/18), 94.44%(17/18) and 61.11% (11/18) in the controls, respectively. The intensities of the expressions of NDRG1, VEGF and Ki-67 in CA tissues were significantly higher than those in the controls. There were significant differences both in the positive rates and the expression intensities of NDRG1, VEGF and Ki-67 between the two groups (P less than0.05). The Spearman’s Rank-Order Correlation analysis indicated that the expressions of NDRG1 protein and VEGF protein were positively correlated by the Spearman’s Rank-Order Correlation analysis (r = 0.346, P=0.016). For the CA tissues with high expressions of NDRG1 and VEGF, NDRG1 and VEGF influenced both the occurrence and development of CA.


Subject(s)
Cell Cycle Proteins/biosynthesis , Condylomata Acuminata/metabolism , Genital Diseases, Female/metabolism , Genital Diseases, Male/metabolism , Intracellular Signaling Peptides and Proteins/biosynthesis , Ki-67 Antigen/biosynthesis , Vascular Endothelial Growth Factor A/biosynthesis , Adolescent , Adult , Cell Cycle Proteins/genetics , Cell Division , Condylomata Acuminata/genetics , Condylomata Acuminata/pathology , Female , Gene Expression Regulation , Genital Diseases, Female/genetics , Genital Diseases, Female/pathology , Genital Diseases, Male/genetics , Genital Diseases, Male/pathology , Humans , Intracellular Signaling Peptides and Proteins/genetics , Ki-67 Antigen/genetics , Male , Middle Aged , Vascular Endothelial Growth Factor A/genetics , Young Adult
4.
J Biol Regul Homeost Agents ; 29(2): 431-6, 2015.
Article in English | MEDLINE | ID: mdl-26122233

ABSTRACT

The objective of the present study was to explore the expression and significance of survivin and Livin in lesions of Condyloma acuminatum (CA). Streptavidin-peroxidase (SP) immunohistochemistry method was used to measure the expression of survivin, Livin and Ki-67 in 48 cases of CA and 25 cases of normal foreskin tissues. The positive expression rates of survivin, Livin and Ki-67 were 72.91% (35/48), 77.08% (37/48) and 85.42% (41/48) in CA tissues, and 4% (1/25), 4% (5/25) and 60% (15/25) in the control group, respectively. The expression intensity of survivin, Livin and Ki-67 in CA tissues (++ ~ +++) was significantly higher than that in the normal control group (- ~ ++). There were significant differences (P <0.05) both in the positive rates and the expression intensity of survivin, Livin and Ki-67 between the two groups. There was positive correlation between the expression of survivin and Livin in CA group (P < 0.01); the expressions of survivin and Ki-67 were positively correlated with each other (P < 0.01); Livin and Ki-67 expressions were positively correlated with each other (P < 0.01). There were over-expressions and excessive proliferations of survivin and Livin in CA tissues, and apoptosis suppressors survivin and Livin were correlated with CA.


Subject(s)
Adaptor Proteins, Signal Transducing/biosynthesis , Condylomata Acuminata/metabolism , Genital Diseases, Female/metabolism , Genital Diseases, Male/metabolism , Inhibitor of Apoptosis Proteins/biosynthesis , Neoplasm Proteins/biosynthesis , Adaptor Proteins, Signal Transducing/genetics , Adolescent , Adult , Apoptosis , Cell Division , Condylomata Acuminata/genetics , Condylomata Acuminata/pathology , Epithelial Cells/metabolism , Female , Genital Diseases, Female/genetics , Genital Diseases, Female/pathology , Genital Diseases, Male/genetics , Genital Diseases, Male/pathology , Humans , Immunoenzyme Techniques , Inhibitor of Apoptosis Proteins/genetics , Ki-67 Antigen/biosynthesis , Ki-67 Antigen/genetics , Male , Middle Aged , Neoplasm Proteins/genetics , Survivin , Young Adult
5.
Br J Radiol ; 85(1019): 1477-81, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22806622

ABSTRACT

OBJECTIVE: The aim of this study was to retrospectively evaluate the technical success rates and clinical effectiveness of fluoroscopically guided nose tube drainage of mediastinal abscesses and a nasojejunum feeding tube in post-operative gastro-oesophageal anastomotic leakage (GEAL). METHODS: From January 2006 to June 2011, 18 cases of post-operative GEAL with mediastinal abscesses after oesophagectomy with intrathoracic oesophagogastric anastomotic procedures for oesophageal and cardiac carcinoma were treated by insertion of a nose drainage tube and nasojejunum feeding tube under fluoroscopic guidance. We evaluated the feasibility of two-tube insertion to facilitate leakage site closure and complete resolution of the abscess, and the patients' nutritional benefit was also evaluated by checking the serum albumin level between pre- and post-enteral feeding via the feeding tube. RESULTS: The two tubes were placed successfully under fluoroscopic guidance in 18 patients (100%). The procedure time for two-tube insertion ranged from 20 to 40 min (mean 30 min). 17 patients (94%) achieved leakage site closure after two-tube insertion and had a good tolerance of two tubes in the nasal cavity. The serum albumin level was significant, increased from pre-enteral feeding (2.49 ± 0.42 g dl(-1)) to the post-enteral feeding (3.58 ± 0.47 g dl(-1)) via the feeding tube (p<0.001). The duration of follow-up ranged from 1 to 49 months (mean 19 months). CONCLUSION: The insertion of nose tube drainage and a nasojejunum feeding tube under fluoroscopic guidance is safe, and it provides effective relief from mediastinal abscesses in GEAL after oesophagectomy. Moreover, our findings indicate that two-tube insertion may be used as a selective procedure to treat mediastinal abscesses in post-operative GEAL. Advances in knowledge Directive drainage of mediastinal abscesses in post-operative GEAL may be an effective treatment.


Subject(s)
Abscess/therapy , Anastomotic Leak/therapy , Drainage/methods , Fluoroscopy/methods , Intubation, Gastrointestinal/methods , Mediastinum , Thoracic Diseases/therapy , Adult , Aged , Female , Humans , Male , Middle Aged
6.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 21(11): 831-3, 2001 Nov.
Article in Chinese | MEDLINE | ID: mdl-12575377

ABSTRACT

OBJECTIVE: To observe the immune modulatory and therapeutical effect of Shenqi tablet (SQT) in treating recurrent genital herpes. METHODS: Sixty-three patients were randomly divided into two groups, the SQT group (34 cases) and the control group (29 cases). The immunologic function of patients was determined before and after treatment and the recurrence rate of two groups was compared. RESULTS: In the SQT group after treatment, CD3, CD4 and CD4/CD8 ratio raised, CD8 percent lowered, serum interleukin 2 (SIL-2) and RBC-C3b raised and serum SIL-2 receptor lowered (all P < 0.05), while in the control group, the above-mentioned parameters were not changed significantly. Follow-up conducted 6 months after treatment showed that the recurrence rate in the SQT group was 26.5% (9 cases), which was lower than that in the control group (72.4%, 21 cases) significantly (P < 0.01). CONCLUSION: SQT has immune modulatory effect in patients with recurrent genital herpes, it could reduce the recurrence rate.


Subject(s)
CD4-CD8 Ratio , Drugs, Chinese Herbal/therapeutic use , Herpes Genitalis/drug therapy , Interleukin-2/blood , Phytotherapy , Adjuvants, Immunologic/therapeutic use , Adolescent , Adult , CD3 Complex/blood , Female , Herpes Genitalis/immunology , Humans , Male , Middle Aged , Recurrence , Tablets
SELECTION OF CITATIONS
SEARCH DETAIL
...